1887

Chapter 22 : Picornavirus Genetics: an Overview

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Picornavirus Genetics: an Overview, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817916/9781555812102_Chap22-1.gif /docserver/preview/fulltext/10.1128/9781555817916/9781555812102_Chap22-2.gif

Abstract:

This chapter overviews the mechanisms underlying the stability and especially the variability of the picornavirus phenotype and genotype. It also talks about the principles of genetic analysis of viral functions and of manipulations with the viral genome. The pathogenic potential of picornaviruses may vary in two respects: (i) viral variants may be more or less virulent, in the sense that different doses of a virus are required to inflict similar clinical signs (at the extreme, even the highest possible dose may fail to produce any signs); and (ii) the variants may cause different clinical patterns. The picornavirus RNA polymerase, like analogous enzymes of other RNA viruses, lacks the ability to remove the erroneously incorporated nucleotide (the proofreading activity), characteristic of many DNA polymerases. Viral RNA rearrangements of any kind (recombination, deletions, insertions) may contribute to genome plasticity and evolution. There are two general approaches to linking specific phenotypic traits to specific genes or their parts: (i) identification of mutations associated with a distinct phenotype, and (ii) observation of phenotypic effects of engineered mutations in specific genes. The current understanding of the mechanisms of picornavirus genome variability and stability is rather superficial and limited.

Citation: Agol V. 2002. Picornavirus Genetics: an Overview, p 269-284. In Semler B, Wimmer E (ed), Molecular Biology of Picornavirus. ASM Press, Washington, DC. doi: 10.1128/9781555817916.ch22

Key Concept Ranking

Theiler's Murine Encephalomyelitis
0.42575505
0.42575505
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Two modes of recombination between RNA genomes. In the replicative mode, the synthesis of a nascent strand is started on one parental RNA molecule and is completed on another, due to template switching. Alternatively, fragments of different parental RNA molecules may be covalently joined in a nonreplicative reaction.

Citation: Agol V. 2002. Picornavirus Genetics: an Overview, p 269-284. In Semler B, Wimmer E (ed), Molecular Biology of Picornavirus. ASM Press, Washington, DC. doi: 10.1128/9781555817916.ch22
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

A model showing how heteroduplex formation may facilitate finding the proper anchoring site upon precise replicative recombination. Two homologous RNA molecules may form a heteroduplex through interaction between identical secondary structure elements. As a result, the to-be parting and anchoring sites on these molecules are brought in close proximity.

Citation: Agol V. 2002. Picornavirus Genetics: an Overview, p 269-284. In Semler B, Wimmer E (ed), Molecular Biology of Picornavirus. ASM Press, Washington, DC. doi: 10.1128/9781555817916.ch22
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817916.chap22
1. Adam, M. A.,, N. Ramesh,, A. D. Miller,, and W. R. Osborne. 1991. Internal initiation of translation in retroviral vectors carrying Picornavirus 5' nontranslated regions. J. Virol. 65:49854990.
2. Agol, V. I. 1997. Recombination and other genomic rearrangements in picornaviruses. Semin. Virol. 8:19.
3. Agol, V. I.,, G. A. Belov,, E. A. Cherkasova,, E. V. Gavrilin,, M. S. Kolesnikova,, L. I. Romanova,, and E. A. Tolskaya. 2001. Some problems of molecular biology of poliovirus infection relevant to pathogenesis and viral spread. Dev. Biol. (Basel) 105:4350.
4. Agol, V. I.,, V. P. Grachev,, S. G. Drozdov,, M. S. Kolesnikova,, V. G. Kozlov,, N. M. Ralph,, L. I. Romanova,, E. A. Tolskaya,, A. V. Tyufanov,, and E. G. Viktorova. 1984. Construction and properties of intertypic poliovirus recombinants: first approximation mapping of the major determinants of neurovirulence. Virology 136:4155.
5. Agol, V. I.,, A. V. Paul,, and E. Wimmer. 1999. Paradoxes of the replication of picornaviral genomes. Virus Res. 62: 129147.
6. Agol, V. I.,, and G. A. Shirman. 1964. Interaction of guanidine-sensitive and guanidine-dependent variants of poliovirus in mixedly infected cells. Biochem. Biophys. Res. Commun. 17:2833.
7. Agut, H.,, K. M. Kean,, O. Fichot,, J. Morasco,, J. B. Flanegan,, and M. Girard. 1989. A point mutation in the poliovirus polymerase gene determines a complementable temperature-sensitive defect of RNA replication. Virology 168:302311.
8. Ahmad, A. L.,, A. B. Dowsett,, and D. A. Tyrrell. 1987. Studies of rhinovirus Resistant to an antiviral chalcone. Antiviral Res. 8:2739.
9. Almond, J. W.,, D. Stone,, K. Burke,, M. A. Skinner,, A. J. Macadam,, D. Wood,, M. Ferguson,, and P. D. Minor. 1993. Approaches to the construction of new candidate poliovirus type 3 vaccine strains. Dev. Biol. Stand. 78:161169.
10. Andino, R.,, G. E. Rieckhof,, D. Trono,, and D. Baltimore. 1990. Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5? noncoding region. J. Virol. 64:607612.
11. Andino, R.,, D. Silvera,, S. D. Suggett,, P. L. Achacoso,, C. J. Miller,, D. Baltimore,, and M. B. Feinberg. 1994. Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science 265:14481451.
12. Armstrong, C. 1939. Successful transfer of the Lansing strain of poliomyelitis virus from the cotton rat to the white mouse. Public Health Rep. 54:23022305.
13. Arnold, J. J.,, and C. E. Cameron. 1999. Poliovirus RNA-dependent RNA polymerase (3Dpol) is sufficient for template switching in vitro. J. Biol. Chem. 274:27062716.
14. Baltera, R. E., Jr.,, and D. R. Tershak. 1989. Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C. J. Virol. 63:44414444.
15. Baranowski, E.,, C. M. Ruiz-Jarabo,, N. Sevilla,, D. An-dreu,, E. Beck,, and E. Domingo. 2000. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J. Virol. 74:16411647.
16. Barclay, W.,, Q. Li,, G. Hutchison,, D. Moon,, A. Richardson,, N. Percy,, J. W. Almond,, and D. J. Evans. 1998. Encapsidation studies of poliovirus subgenomic replicons. J. Gen. Virol. 79:17251734.
17. Bell, Y. C.,, B. L. Semler,, and E. Ehrenfeld. 1999. Requirements for RNA replication of a poliovirus replicon by coxsackievirus B3 RNA polymerase. J. Virol. 73:94139421.
18. Beneduce, E.,, G. Pisani,, M. Divizia,, A. Pana,, and G. Morace. 1995. Complete nucleotide sequence of a cytopathic hepatitis A virus strain isolated in Italy. Virus Res. 36:299309.
19. Bergstrom, C. T.,, P. McElhany,, and L. A. Real. 1999. Transmission bottlenecks as determinants of virulence in rapidly evolving pathogens. Proc. Natl. Acad. Sci. USA 96:50955100.
20. Bernstein, H. D.,, P. Sarnow,, and D. Baltimore. 1986. Genetic complementation among poliovirus mutants derived from an infectious cDNA clone. J. Virol. 60:10401049.
21. Bernstein, H. D.,, N. Sonenberg,, and D. Baltimore. 1985. Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol. Cell. Biol. 5:29132923.
22. Bodian, D.,, L. M. Morgan,, and H. A. Howe. 1949. Differentiation of types of poliomyelitis virus. III. The grouping of fourteen strains into three basic immunological types. Am. J. Hyg. 49:234245.
23. Boeyé, U.,, D. Kobasa,, S. Onodera,, G. D. Parks,, A. C. Palmenberg,, and D. G. Scraba. 1991. Characterization of mengo virus neutralization epitopes. Virology 181:113.
24. Boeye, A. 1959. Induction of mutation in poliovirus by nitrous acid. Virology 9:691700.
25. Bolwell, C.,, B. E. Clarke,, N. R. Parry,, E. J. Ouldridge,, F. Brown,, and D. J. Rowlands. 1989. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. J. Gen. Virol. 70:5968.
26. Bradley, D. W.,, C. A. Schable,, K. A. McCaustland,, E. H. Cook,, B. L. Murphy,, H. A. Fields,, J. W. Ebert,, C. Wheeler,, and J. E. Maynard. 1984. Hepatitis A virus: growth characteristics of in vivo and in vitro propagated wild and attenuated virus strains. J. Med. Virol. 14:373386.
27. Brooksby, J. B. 1958. The virus of foot-and-mouth disease. Adv. Virus Res. 5:137.
28. Bunch, T.,, E. Rieder,, and P. Mason. 1994. Sequence of the S fragment of foot-and-mouth disease virus type A12. Virus Genes 8:173175.
29. Burke, K. L.,, D. J. Evans,, O. Jenkins,, J. Meredith,, E. D. D'Souza,, and J. W. Almond. 1989. A cassette vector for the construction of antigen chimaeras of poliovirus. J. Gen. Virol. 70:24752479.
30. Burnet, F. M.,, and J. Macnamara. 1931. Immunological differences between strains of poliomyelitis virus. Br. J. Exp. Pathol. 12:5761 (quoted in reference 73).
31. Cammack, N.,, A. Phillips,, G. Dunn,, V. Patel,, and P. D. Minor. 1988. Intertypic genomic rearrangements of poliovirus strains in vaccinees. Virology 167:507514.
32. Cao, X.,, and E. Wimmer. 1995. Intragenomic complementation of a 3AB mutant in dicistronic polioviruses. Virology 209:315326.
33. Cao, X. M.,, I. E. Bergmann,, and E. Beck. 1991. Comparison of the 5' and 3' untranslated genomic regions of virulent and attenuated foot-and-mouth disease viruses (strains Ol Campos and C3 Resende). J. Gen. Virol. 72: 28212825.
34. Chapman, N. M.,, A. Ragland,, J. S. Leser,, K. Hofling,, S. Willian,, B. L. Semler,, and S. Tracy. 2000. A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice. J. Virol. 74:40474056.
35. Chapman, N. M.,, A. I. Ramsingh,, and S. Tracy. 1997. Genetics of coxsackievirus virulence. Curr. Top. Microbiol. 223:227258.
36. Charini, W. A.,, C. C. Burns,, E. Ehrenfeld,, and B. L. Semler. 1991. trans rescue of a mutant poliovirus RNA polymerase function. J. Virol. 65:26552665.
37. Charini, W. A.,, S. Todd,, G. A. Gutman,, and B. L. Semler. 1994. Transduction of a human RNA sequence by poliovirus. J. Virol. 68:65476552.
38. Charpentier, N.,, M. Davila,, E. Domingo,, and C. Escarmis. 1996. Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene. Virology 223: 1018.
38a. Cherkasova, E. A.,, E. A. Korotkova,, M. L. Yakovenko,, O. E. Ivanova,, T. P. Eremeeva,, K. M. Chumakov,, and V. I. Agol. 2002. Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J. Virol. 76:67916799.
39. Chetverin, A. B. 1999. The puzzle of RNA recombination. FEBS Lett. 460:15.
40.> Chetverin, A. B.,, H. V. Chetverina,, A. A. Demidenko,, and V. I. Ugarov. 1997. Nonhomologous RNA recombination in a cell-free system: evidence for a transesterification mechanism guided by secondary structure. Cell 88:503513.
41. Cole, C. N.,, and D. Baltimore. 1973. Defective interfering particles of poliovirus. II. Nature of the defect. J. Mol. Biol. 76:325343.
42. Cole, C. N.,, D. Smoler,, E. Wimmer,, and D. Baltimore. 1971. Defective interfering particles of poliovirus. I. Isolation and physical properties. J. Virol. 7:478485.
43. Colston, E. M.,, and V. R. Racaniello. 1995. Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J. Virol. 69:48234829.
44. Colter, J. S.,, H. H. Bird,, A. W. Mover,, and R. A. Brown. 1957. Infectivity of ribonucleic acid isolated from virus infected tissues. Virology 4:522532.
45. Cooper, P. D. 1968. A genetic map of poliovirus temperature-sensitive mutants. Virology 35:584596.
46. Cooper, P. D. 1977. Genetics of picornaviruses. Comp. Virol. 9:133207.
47. Cords, C. E.,, and J. J. Holland. 1964. Interference between enteroviruses and conditions affecting its reversal. Virology 22:226234.
48. Cords, C. E.,, and J. J. Holland. 1964. Replication of poliovirus RNA induced by heterologous virus. Proc. Natl. Acad. Sci. USA 51:10801082.
49. Couderc, T.,, J. Hogle,, H. Le Blay,, F. Horaud,, and B. Blondel. 1993. Molecular characterization of mouse-virulent poliovirus type I Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell. J. Virol. 67: 38083817.
49a. Crotty, S.,, C. E. Cameron,, and R. Andino. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 98:68956900.
50. Crowell, R. L.,, and B. J. Landau. 1983. Receptors in the initiation of Picornavirus infection. Comp. Virol. 18: 143.
51. Curran, J.,, and D. Kolakofsky. 1999. Replication of paramyxoviruses. Adv. Virus Res. 54:403422.
52. Day, S. P.,, P. Murphy,, E. A. Brown,, and S. M. Lemon. 1992. Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-l cells. J. Virol. 66:65336540.
53. de la Torre, J. C.,, C. Giachetti,, B. L. Semler,, and J. J. Holland. 1992. High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc. Natl. Acad. Sci. USA 89: 25312535.
54. de la Torre, J. C.,, E. Wimmer,, and J. J. Holland. 1990. Very high frequency of reversion to guanidine resistance in clonal pools of guanidine-dependent type 1 poliovirus. J. Virol. 64:664671.
55. Dewalt, P. G.,, M. A. Lawson,, R. J. Colonno,, and B. L. Semler. 1989. Chimeric Picornavirus polyproteins demonstrate a common 3C proteinase substrate specificity. J. Virol. 63:34443452.
56. Diez, J.,, M. Hofner,, E. Domingo,, and A. I. Donaldson. 1990. Foot-and-mouth disease virus strains isolated from persistantly infected cell cultures are attenuated for mice and cattle. Virus Res. 18:37.
57. Diez, J.,, M. G. Mateu,, and E. Domingo. 1989. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay. J. Gen. Virol. 70:32813289.
58. Dildine, S. L.,, and B. L. Semler. 1989. The deletion of 41 proximal nucleotides reverts a poliovirus mutant containing a temperature-sensitive lesion in the 5'noncoding region of genomic RNA. J. Virol. 63:847862.
59. Domingo, E.,, M. Davila,, and J. Ortin. 1980. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth-disease virus. Gene 11:333346.
60. Domingo, E.,, C. Escarmis,, L. Menéndez-Arias,, and J. J. Holland,. 1999. Viral quasi-species and fitness variations, p. 141161. In E. Domingo,, R. G. Webster,, and J. J. Holland (ed.), Origin and Evolution of Viruses. Academic Press, San Diego, Calif.
61. Domingo, E.,, and J. J. Holland. 1997. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51: 151178.
62. Domingo, E.,, E. Martinez-Salas,, F. Sobrino,, J. C. de la Torre,, A. Portela, J. Ortin,, C. Lopez-Galindez,, P. Perez-Brena,, N. Villanueva,, R. Najera,, S. VandePol,, D. Steinhauer,, N. De Polo,, and J. J. Holland. 1985. The quasi-species (extremely heterogeneous) nature of viral RNA genome populations: biological relevance—a review. Gene 40:18.
63. Dove, A., W, and V. R. Racaniello. 1997. Cold-adapted poliovirus mutants bypass a postentry replication block. J. Virol. 71:47284735.
64. Drake, J. W.,, and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 96: 1391013913.
65. Duarte, E.,, D. Clarke,, A. Moya,, E. Domingo,, and J. Holland. 1992. Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet. Proc. Natl. Acad. Sci. USA 89:60156019.
66. Dubes, G. R.,, and M. Chapin. 1956. Cold-adapted genetic variants of polioviruses. Science 124:586588.
67. Duggal, R.,, and E. Wimmer. 1999. Genetic recombination of poliovirus in vitro and in vivo: temperature-dependent alteration of crossover sites. Virology 258:3041.
68. Duke, G. M.,, J. E. Osorio,, and A. C. Palmenberg. 1990. Attenuation of mengo virus through genetic engineering of the 5' noncoding poly(C) tract. Nature 343:474476.
69. Dulbecco, R.,, and M. Vogt. 1954Plaque formation and isolation of pure lines with polioviruses. J. Exp. Med. 99: 167182.
70. Dulbecco, R.,, and M. Vogt. 1958. Studies on the induction of mutations in poliovirus by proflavine. Virology 5: 236243.
71. Dunn, J. J.,, N. M. Chapman,, S. Tracy,, and J. R. Romero. 2000. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5? nontranslated region. J. Virol. 74:47874794.
72. Egger, D.,, N. Teterina,, E. Ehrenfeld,, and K. Bienz. 2000. Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J. Virol. 74:65706580.
73. Eggers, H. J. 1999. Milestones in early poliomyelitis research (1840 to 1949). J. Virol. 73:45334535.
74. Eggers, H. J.,, and B. Rosenwirth. 1988. Isolation and characterization of an arildone-resistant poliovirus 2 mutant with an altered capsid protein VP1. Antiviral Res. 9: 2335.
75. Eggers, H. J.,, and I. Tamm. 1962. On the mechanism of selective inhibition of enterovirus multiplication by 2-(α-hydroxybenzyl)-benzimidazole. Virology 18:426438.
76. Elena, S. F.,, F. Gonzalez-Candelas,, and A. Moya. 1992. Does the VP1 gene of foot-and-mouth disease virus behave as a molecular clock? J. Mol. Evol. 35:223229.
77. Emerson, S. U.,, Y. K. Huang,, C. McRill,, M. Lewis,, and R. H. Purcell. 1992. Mutations in both the 2B and 2C genes of hepatitis A virus are involved in adaption to growth in cell culture. J. Virol. 66:650654.
78. Emini, E. A.,, B. A. Jameson,, A. J. Lewis,, G. R. Larsen,, and E. Wimmer. 1982. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J. Virol. 43:9971005.
79. Emini, E. A.,, J. Leibowitz,, D. C. Diamond,, J. Bonin,, and E. Wimmer. 1984. Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phe-notypic markers and evidence that resistance to guanidine maps in the nonstructural proteins. Virology 137:7485.
80. Enders, J. F.,, T. H. Weiler,, and F. C. Robbins. 1949. Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109: 8587.
81. Escarmis, C.,, M. Davila,, N. Charpentier,, A. Bracho,, A. Moya,, and E. Domingo. 1996. Genetic lesions associated with Muller's ratchet in an RNA virus. J. Mol. Biol. 264: 255267.
82. Escarmis, C.,, M. Davila,, and E. Domingo. 1999. Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet. J. Mol. Biol. 285:495505.
83. Escarmis, C.,, J. Dopazo,, M. Davila,, E. L. Palma,, and E. Domingo. 1995. Large deletions in the 5?-untranslated region of foot-and-mouth disease virus of serotype C. Virus Res. 35:155167.
84. Escarmis, C.,, M. Toja,, M. Medina,, and E. Domingo. 1992. Modifications of the 5? untranslated region of foot-and-mouth disease virus after prolonged persistence in cell culture. Virus Res. 26:113125.
85. Gavrilin, G. V.,, E. A. Cherkasova,, G. Yu,, Lipskaya,, O. M. Kew,, and V. I. Agol. 2000. Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J. Virol. 74: 73817390.
86. Genschik, P.,, E. Billy,, M. Swianiewicz,, and W. Filipowicz. 1997. The human RNA 3?-terminal phosphate cyclase is a member of a new family of proteins conserved in Eucarya, Bacteria and Archaea. EMBO J. 16:29552967.
87. Georgescu, M. M.,, F. Delpeyroux,, M. Tardy-Panit,, J. Balanant,, M. Combiescu,, A. A. Combiescu,, S. Guillot,, and R. Crainic. 1994. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 68:80898101.
88. Ghendon, Y. Z. 1972. Conditional-lethal mutants of animal viruses. Prog. Med. Virol. 14:6890.
89. Giachetti, C.,, S. S. Hwang,, and B. L. Semler. 1992. cis-acting lesions targeted to the hydrophobic domain of a poliovirus membrane protein involved in RNA replication. J. Virol. 66:60456057.
90. Gmyl, A. P.,, E. V. Belousov,, S. V. Maslova,, E. V. Khitrina,, A. B. Chetverin, and V. I. Agol. 1999. Nonreplicative RNA recombination in poliovirus. J. Virol. 73: 89588965.
91. Gmyl, A. P.,, E. V. Pilipenko,, S. V. Maslova,, G. A. Belov, and V. I. Agol. 1993. Functional and genetic plasticities of the poliovirus genome: quasi-infectious RNAs modified in the 5'-untranslated region yield a variety of pseudorevertants. J. Virol. 67:63096316.
92. Gojobori, T.,, E. N. Moriyama,, and M. Kimura. 1990. Molecular clock of viral evolution, and the neutral theory. Proc. Natl. Acad. Sci. USA 87:1001510018.
93. Goodfellow, I.,, Y. Chaudhry,, A. Richardson,, J. Meredith,, J. W. Almond,, W. Barclay,, and D. J. Evans. 2000. Identification of a cis-acting replication element within the poliovirus coding region. J. Virol. 74:45904600.
94. Graff, J.,, C. Kasang,, A. Normann,, M. Pfisterer-Hunt,, S. M. Feinstone,, and B. Flehmig. 1994. Mutational events in consecutive passages of hepatitis A virus strain GBM during cell culture adaptation. Virology 204:6068.
95. Graff, J.,, A. Normann,, and B. Flehmig. 1997. Influence of the 5' noncoding region of hepatitis A virus strain GBM on its growth in different cell lines. J. Gen. Virol. 78:18411849.
96. Gromeier, M.,, L. Alexander,, and E. Wimmer. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in inter-generic poliovirus recombinants. Proc. Natl. Acad. Sci. USA 93:23702375.
97. Gromeier, M.,, B. Bossert,, M. Arita,, A. Nomoto,, and E. Wimmer. 1999. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J. Virol. 73:958964.
98. Gromeier, M.,, E. Wimmer,, and A. E. Gorbalenya,. 1999. Genetics, pathogenesis and evolution of picornaviruses, p. 287343. In E. Domingo,, R. G. Webster,, and J. J. Holland (ed.), Origin and Evolution of Viruses. Academic Press, San Diego, Calif.
99. Guillot, S.,, V. Caro,, N. Cuervo,, E. Korotkova,, M. Combiescu,, A. Persu,, A. Aubert-Combiescu,, F. Delpeyroux,, and R. Crainic. 2000. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J. Virol. 74:84348443.
100. Hadfield, A. T.,, M. A. Oliveira,, K. H. Kim,, I. Minor,, M. J. Kremer,, B. A. Heinz,, D. Shepard,, D. C. Pevear,, R. R. Rueckert,, and M. G. Rossmann. 1995. Structural studies on human rhinovirus 14 drug-resistant compensation mutants. J. Mol. Biol. 253:6173.
101. Hagino-Yamagishi, K.,, and A. Nomoto. 1989. In vitro construction of poliovirus defective interfering particles. J. Virol. 63:53865392.
102. Harris, T. J.,, and F. Brown. 1977. Biochemical analysis of a virulent and an avirulent strain of foot-and-mouth disease virus. J. Gen. Virol. 34:87105.
103. Heinz, B. A.,, R. R. Rueckert,, D. A. Shepard,, F. J. Dutko,, M. A. McKinlay,, M. Fancher, M. G. Rossmann,, J. Badger,, and T. J. Smith. 1989. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 63:24762485.
104. Hirst, G. K. 1962. Genetic recombination with Newcastle disease virus, polioviruses and influenza. Cold Spring Harbor Symp. Quant. Biol. 27:303308.
105. Holland, J. J.,, E. Domingo,, J. C. de la Torre,, and D. A. Steinhauer. 1990. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J. Virol. 64:39603962.
106. Hughes, P. J.,, C. North,, P. D. Minor,, and G. Stanway. 1989. The complete nucleotide sequence of coxsackievirus A21. J. Gen. Virol. 70:29432952.
107. Huovilainen, A.,, T. Hovi,, L. Kinnunen,, K. Takkinen,, M. Ferguson,, and P. Minor. 1987. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. J. Gen. Virol. 68:13731378.
108. Huovilainen, A.,, L. Kinnunen,, M. Ferguson,, and T. Hovi. 1988. Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak. J. Gen. Virol. 69:19411848.
109. Iizuka, N.,, M. Kohara,, K. Hagino-Yamagishi,, S. Abe,, T. Komatsu,, K. Tago,, M. Arita,, and A. Nomoto. 1989. Construction of less neurovirulent polioviruses by introducing deletions into the 5? noncoding sequence of the genome. J. Virol. 63:53545363.
110. Ishiko, H.,, N. Takeda,, K. Miyamura,, N. Kato,, M. Tanimura,, K. H. Lin,, M. Yin-Murphy,, J. S. Tam,, G. F. Mu,, and S. Yamazaki. 1992. Phylogenetic analysis of a coxsackievirus A24 variant: the most recent worldwide pandemic was caused by progenies of a virus prevalent around 1981. Virology 187:748759.
111. Jackson, T.,, D. Sheppard,, M. Denyer,, W. Blakemore,, and A. M. King. 2000. The epithelial integrin alphavbetao is a receptor for foot-and-mouth disease virus. J. Virol. 74:49494956.
112. Jakob, J.,, and R. P. Roos. 1996. Molecular determinants of Theiler's murine encephalomyelitis-induced disease. J. Neurovirol. 2:7077.
113. Jarvis, T. C.,, and K. Kirkegaard. 1991. The polymerase in its labyrinth: mechanisms and implications of RNA recombination. Trends Genet. 7:186191.
114. Jarvis, T. C.,, and K. Kirkegaard. 1992. Poliovirus RNA recombination: mechanistic studies in the absence of selection. EMBO J. 11:31353145.
115. Jia, Q.,, S. Ohka,, K. Iwasaki,, K. Tohyama,, and A. Nomoto. 1999. Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice. J. Virol. 73:60416047.
116. Johnson, K. L.,, and P. Sarnow. 1991. Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus. J. Virol. 65:43414349.
117. Johnson, V. H.,, and B. L. Semler. 1988. Defined recombinants of poliovirus and coxsackievirus: sequence-specific deletions and functional substitutions in the 5'-noncoding regions of viral RNAs. Virology 162:4757.
118. Kaplan, G.,, and V. R. Racaniello. 1988. Construction and characterization of poliovirus subgenomic replicons. J. Virol. 62:16871696.
119. Karron, R. A.,, R. Daemer,, J. Ticehurst,, E. D'Hondt,, H. Popper,, K. Mihalik,, J. Philips,, S. Feinstone,, and R. H. Purcell. 1988. Studies of prototype live hepatitis A virus vaccines in primate models. J. Infect. Dis. 157: 338345.
119a. Kew, O.,, V. Morris-Glasgow,, M. Landaverde,, C. Burns,, J. Shaw,, Z. Garib,, J. Andre,, E. Blackman,, C. J. Freeman,, J. Jorba,, R. Sutter,, G. Tambinia,, L. Venczel,, C. Perdreira,, F. Laender,, H. Shimizu,, T. Yoneyama,, T. Miyamura,, H. van der Avoort,, M. S. Oberste,, D. Kilpatrick,, S. Cochi,, M. Pallansch,, and C. de Quadros. 2002. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296:356359.
120. Kew, O. M.,, M. N. Mulders,, G. Y. Lipskaya,, E. E. da Silva,, and M. A. Pallansch. 1995. Molecular epidemiology of poliovirus. Semin. Virol. 6:401414.
121. Kimura, M. 1983. The Neutral Theory of Molecular Evolution. Cambridge University Press, Cambridge, United Kingdom.
122. King, A. M. 1988. Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences. Nucleic Acids Res. 16:1170511723.
123. King, A. M.,, D. McCahon,, W. R. Slade,, and J. W. Newman. 1982. Recombination in RNA. Cell 29:921928.
124. Kinnunen, L.,, A. Huovilainen,, T. Poyry,, and T. Hovi. 1990. Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts. J. Gen. Virol. 71:317324.
125. Kirkegaard, K.,, and D. Baltimore. 1986. The mechanism of RNA recombination in poliovirus. Cell 47:433443.
126. Kitamura, N.,, B. L. Semler,, P. G. Rothberg,, G. R. Larsen,, C. J. Adler,, A. J. Dorner,, E. A. Emini,, R. Hanecak,, J. J. Lee,, S. Werf,, C. W. Anderson,, and E. Wimmer. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 291: 547553.
127. Koch, F.,, and G. Koch. 1985. The Molecuhr Biology of Poliovirus. Springer-Verlag, Vienna, Austria.
128. Kohara, M.,, T. Omata,, A. Kameda,, B. L. Semler,, H. Itoh, E. Wimmer,, and A. Nomoto. 1985. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Ma-honey strain and the attenuated Sabin 1 strain. J. Virol. 53:786792.
129. Koprowski, H.,, G. A. Jarvis,, and T. W. Norton. 1952. Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus. Am. J. Hyg. 55:108126.
130. Krebs, O.,, and O. Marquardt. 1992. Identification and characterization of foot-and-mouth disease virus O1 Burgwedel/1987 as an intertypic recombinant. J. Gen. Virol. 73:613619.
131. Kuge, S.,, N. Kawamura,, and A. Nomoto. 1989. Strong inclination toward transition mutation in nucleotide substitutions by poliovirus replicase. J. Mol. Biol. 207: 175182.
132. Kuge, S.,, N. Kawamura,, and A. Nomoto. 1989. Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1. J. Virol. 63:10691075.
133. Kuge, S.,, and A. Nomoto. 1987. Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J. Virol. 61:14781487.
137. 134Kuge, S.,, I. Saito,, and A. Nomoto. 1986. Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J. Mol. Biol. 192:473487.
135. Lafontaine, D.,, D. Beaudry,, P. Marquis,, and J. P. Perreault. 1995. Intra- and intermolecular nonenzymatic ligations occur within transcripts derived from the peach latent mosaic viroid. Virology 212:705709.
136. La Monica, N.,, C. Meriam,, and V. R. Racaniello. 1986. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J. Virol. 57:515525.
137. Ledinko, N. 1963. Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain. Virology 20:107119.
138. Ledinko, N.,, and G. K. Hirst. 1961. Mixed infection of HeLa cells with polioviruses types 1 and 2. Virology 14: 107119.
139. Li, C. P.,, and K. Habel. 1951. Adaptation of Leon strain of poliomyelitis virus to mice. Proc. Soc. Exp. Biol. Med. 78:233238.
140. Li, C. P.,, and M. Schaeffer. 1953. Adaptation of type 1 poliomyelitis virus to mice. Proc. Soc. Exp. Biol. Med. 82:477481.
141. Li, J. P.,, and D. Baltimore. 1988. Isolation of poliovirus 2C mutants defective in viral RNA synthesis. J. Virol. 62:40164021.
142. Li, J. P.,, and D. Baltimore. 1990. An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J. Virol. 64:11021107.
143. Lipskaya, G. Y.,, E. A. Chervonskaya,, G. I. Belova,, S. V. Maslova,, T. N. Kutateladze,, S. G. Drozdov,, M. Mulders,, M. A. Pallansch,, O. M. Kew,, and V. I. Agol. 1995. Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J. Gen. Virol. 76: 16871699.
144. Lipskaya, G. Y.,, A. R. Muzychenko,, O. K. Kutitova,, S. V. Maslova,, M. Equestre, S. G. Drozdov,, R. R. Perez Bercoff,, and V. I. Agol. 1991. Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. J. Med. Virol. 35: 290296.
145. Lipton, H. L.,, and M. L. Jelachich. 1997. Molecular pathogenesis of Theiler's murine encephalomyelitis virus-induced demyelinating disease in mice. Intervirology 40: 143152.
146. Loddo, B.,, W. Ferrari,, A. Spaneda,, and G. Brotzu. 1962. In vitro guanidine-resistance and guanidine-dependence of poliovirus. Experientia 18:518519.
147. Lu, H. H.,, X. Li,, A. Cuconati,, and E. Wimmer. 1995. Analysis of Picornavirus 2A(pro) proteins: separation of proteinase from translation and replication functions. J. Virol. 69:74457452.
148. Lwoff, A. Factors influencing evolution of viral disease at the cellular level and in the organism. Bacteriol. Rev. 23:109124.
149. Mandl, S.,, L. J. Sigal,, K. L. Rock,, and R. Andino. 1998. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen. Proc. Natl. Acad. Sci. USA 95:82168221.
150. Martin, L. R.,, Z. C. Neal,, M. S. McBride,, and A. C. Palmenberg. 2000. Mengovirus and encephalomyocarditis virus poly(C) tract lengths can affect virus growth in murine cell culture. J. Virol. 74:30743081.
151. Martinez, M. A.,, C. Carrillo,, F. Gonzalez-Candelas,, A. Moya,, E. Domingo,, and F. Sobrino. 1991. Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J. Virol. 65: 39543957.
152. Martinez, M. A.,, J. Dopazo,, J. Hernandez,, M. G. Mateu,, F. Sobrino,, E. Domingo,, and N. J. Knowles. 1992. Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. J. Virol. 66: 35573565.
153. Martinez, M. A.,, N. Verdaguer,, M. G. Mateu,, and E. Domingo. 1997. Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 94:67986802.
154. Marvil, P.,, N. J. Knowles,, A. P. Mockett,, P. Britton,, T. D. Brown,, and D. Cavanagh. 1999. Avian encephalomyelitis virus is a Picornavirus and is most closely related to hepatitis A virus. J. Gen. Virol. 80:653662.
155. Mason, P. W.,, M. E. Piccone,, T. S. Mckenna,, J. Chinsangaram,, and M. J. Grubman. 1997. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227:96102.
156. Melchers, W. J.,, J. M. Bakkers,, H. J. Bruins Slot,, J. M. Galama,, V. I. Agol,, and E. V. Pilipenko. 2000. Crosstalk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR. RNA 6:976987.
157. Melchers, W. J. G.,, H. Heenderop,, H. J. Bruins Slot,, C. Pleij,, E. V. Pilipenko,, V. I. Agol,, and J. Galama. 1997. Kissing of the two predominant hairpin loops in the Coxsackie B virus 3'UTR in the origin of replication required for (—) strand RNA synthesis. J. Virol. 71:686696.
158. Melnick, J. L. 1953. Poliomyelitis. Adv. Virus Res. 1: 229275.
159. Melnick, J. L., 1996. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, p. 655712. In B. N. Fields,, D. M. Knipe,, and P. M. Howley (ed.), Fields Virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
160. Melnick, J. L.,, D. Crowther,, and J. Barrera-Oro. 1961. Rapid development of drug resistant mutants of poliovirus. Science 134:557.
161. Meredith, J. M.,, J. B. Rohll,, J. W. Almond,, and D. J. Evans. 1999. Similar interactions of the poliovirus and rhinovirus 3D polymerases with the 3' untranslated region of rhinovirus 14. J. Virol. 73:99529958.
162. Minor, P. D.,, A. M. John,, M. Ferguson,, and J. P. Icenogle. 1986. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J. Gen. Virol. 67: 693706.
163. Minor, P. D.,, G. C. Schild,, J. Bootman,, D. M. Evans,, M. Ferguson,, P. Reeve,, M. Spitz,, G. Stanway,, A. J. Cann,, R. Hauptmann,, L. D. Clarke,, R. C. Mountford,, and J. W. Almond. 1983. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature 301:674679.
164. Mirmomeni, M. H.,, P. J. Hughes,, and G. Stanway. 1997. An RNA structure in the 3' untranslated region of enteroviruses is necessary for efficient replication. J. Virol. 71:23632370.
165. Molla, A.,, A. V. Paul,, and E. Wimmer. 1991. Cell-free, de novo synthesis of poliovirus. Science 254:16471651.
166. Mosser, A. G.,, and R. R. Rueckert. 1993. WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present. J. Virol. 67:12461254.
167. Mueller, S.,, and E. Wimmer. 1998. Expression of foreign proteins by poliovirus polyprotein fusion: analysis of genetic stability reveals deletions and formation of cardioviruslike open reading frames. J. Virol. 72:2031.
168. Mulders, M. N.,, G. Y. Lipskaya,, H. G. A. M. van der Avoort,, M. P. G. Koopmans,, O. M. Kew,, and A. M. van Loon. 1995. Molecular epidemiology of wild poliovirus type 1 in Europe, the Middle East and the Indian subcontinent. J. Infect. Dis. 171:13991405.
169. Mulders, M. N.,, J. H. Reimerink,, M. Stenvik,, I. Alaeddinoglu,, H. G. van der Avoort,, T. Hovi,, and M. P. Koopmans. 1999. ? Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J. Gen. Virol. 80:907916.
170. Murakami, M.,, H. Watanabe,, Y. Niikura,, T. Kameda,, K. Saitoh,, M. Yamamoto,, Y. Yokouchi,, A. Kuroiwa,, K. Mizumoto,, and H. Iba. 1997. High-level expression of exogenous genes by replication-component retrovirus vectors with an internal ribosomal entry site. Gene 202: 2329.
171. Neff, S.,, D. Sa-Carvalho,, E. Rieder,, P. W. Mason,, S. D. Blystone,, E. J. Brown,, and B. Baxt. 1998. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J. Virol. 72:35873594.
172. Novak, J. E.,, and K. Kirkegaard. 1994. Coupling between genome translation and replication in an RNA virus. Genes Dev. 8:17261737.
173. Novak, M. J.,, L. E. Smythies,, S. A. McPherson,, P. D. Smith,, and C. D. Morrow. 1999. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Thl associated immune response. Vaccine 17: 23842391.
174. Nugent, C. I.,, K. L. Johnson,, P. Saraow,, and K. Kirkegaard. 1999. Functional coupling between replication and packaging of poliovirus replicon RNA. J. Virol. 73:427435.
175. Pata, J. D.,, S. C. Schultz,, and K. Kirkegaard. 1995. Functional oligomerization of poliovirus RNA-dependent RNA polymerase. RNA 1:466477.
176. Paul, A. V.,, J. H. van Boom,, D. Filippov,, and E. Wimmer. 1998. Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature 393:280284.
177. Pilipenko, E. V.,, V. M. Blinov,, and V. I. Agol. 1990. Gross rearrangements within the 5'-untranslated region of the picornaviral genomes. Nucleic Acids Res. 18: 33713375.
178. Pilipenko, E. V.,, A. P. Gmyl,, and V. I. Agol. 1995. A model for rearrangements in RNA genomes. Nucleic Acids Res. 23:18701875.
179. Pilipenko, E. V.,, A. P. Gmyl,, S. V. Maslova,, E. V. Khitrina,, and V. I. Agol. 1995. Attenuation of Theiler's murine encephalomyelitis virus by modifications of the oligopyrimidine/AUG tandem, a host-dependent translational cis-element. J. Virol. 69:864870.
180. Pilipenko, E. V.,, A. P. Gmyl,, S. V. Maslova,, Y. V. Svitkin,, A. N. Sinyakov,, and V. I. Agol. 1992. A prokaryotic-like cis-element in the cap-independent internal initiation of translation on Picornavirus RNA. Cell 68:119131.
181. Pilipenko, E. V.,, T. V. Pestova,, V. G. Kolupaeva,, E. V. Khitrina,, A. N. Poperechnaya,, V. I. Agol,, and C. U. Hellen. 2000. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev. 14:20282045.
182. Pilipenko, E. V.,, K. V. Poperechny,, S. V. Maslova,, W. J. G. Melchers,, H. J. Bruins Slot,, and V. I. Agol. 1996. Cis-element, oriR, involved in the initiation of (—) strand poliovirus RNA: a quasi-globular multi-domain RNA structure maintained by tertiary (“kissing”) interaction. EMBO J. 19:54285436.
183. Pilipenko, E. V.,, E. G. Viktorova,, E. V. Khitrina,, S. V. Maslova,, N. Jarousse,, M. Brahic,, and V. I. Agol. 1999. Distinct attenuation phenotypes caused by mutations in the translational starting window of Theiler's murine encephalomyelitis virus. J. Virol. 73:31903196.
184. Pincus, S. E.,, H. Rohl,, and E. Wimmer. 1987. Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements. Virology 157:8388.
185. Porter, D. C.,, D. C. Ansardi,, and C. D. Morrow. 1995. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans. J. Virol. 69:15481555.
186. Porter, D. C.,, D. C. Ansardi,, J. Wang,, S. McPherson,, Z. Moldoveanu,, and C. D. Morrow. 1998. Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase. Virology 243:111.
187. Poyry, T.,, L. Kinnunen,, J. Kapsenberg,, O. Kew,, and T. Hovi. 1990. Type 3 poliovirus/Finland/1984 is genetically related to common Mediterranean strains. J. Gen. Virol. 71:25352541.
188. Provost, P. J.,, P. A. Conti,, P. A. Giesa,, F. S. Banker,, E. B. Buynak,, W. J. McAleer,, and M. R. Hilleman. 1983. Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates. Proc. Soc. Exp. Biol. Med. 172:357363.
189. Racaniello, V. R.,, and D. Baltimore. 1981. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc. Natl. Acad. Sci. USA 78:48874891.
190. Racaniello, V. R.,, and D. Baltimore. 1981. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 214:916919.
191. Ramesh, N.,, S. T. Kim,, M. Q. Wei,, M. Khalighi,, and W. R. Osborne. 1996. High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site. Nucleic Acids Res. 24:26972700.
192. Reid, C. E.,, and D. W. Lazinski. 2000. A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs. Proc. Natl. Acad. Sci. USA 97:424429.
193. Rico-Hesse, R.,, M. A. Pallansch,, B. K. Nottay,, and O. M. Kew. 1987. Geographic distribution of wild poliovirus type 1 genotypes. Virology 160:311322.
194. Rieder, E.,, T. Bunch,, F. Brown,, and P. W. Mason. 1993. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67:51395345.
195. Rightsel, W. A.,, J. R. Dice,, R. J. McAlpine,, E. A. Timm,, I. W. McLean,, G. J. Dixon,, and F. M. Schabel. 1961. Antiviral effect of guanidine. Science 134:558559.
196. Roberts, L. O.,, and G. J. Belsham. 1997. Complementation of defective Picornavirus internal ribosome entry site (IRES) elements by the coexpression of fragments of the IRES. Virology 227:5362.
197. Roca-Garcia, M.,, A. W. Moyer,, and H. R. Cox. 1953. Poliomyelitis. 2. Propagation of MEF-1 strain of poliomyelitis virus in developing chick embryo by yolk sac inoculation. Proc. Soc. Exp. Biol. Med. 81:519525.
198. Rohll, J. B.,, D. H. Moon,, D. J. Evans,, and J. W. Almond. 1995. The 3? untranslated region of Picornavirus RNA: features required for efficient genome replication. J. Virol. 69:78357844.
199. Romanova, L. I.,, V. M. Blinov,, E. A. Tolskaya,, E. G. Viktorova,, M. S. Kolesnikova,, E. A. Guseva,, and V. I. Agol. 1986. The primary structure of crossover regions of intertypic poliovirus recombinants: a model of recombination between RNA genomes. Virology 155:202213.
200. Romanova, L. I.,, E. A. Tolskaya,, M. S. Kolesnikova,, and V. I. Agol. 1980. Biochemical evidence for intertypic genetic recombination of polioviruses. FEBS Lett. 1:109112.
201. Rose, C.,, W. Andrews,, M. Ferguson,, J. McKeating,, J. Almond,, and D. Evans. 1994. The construction and characterization of poliovirus antigen chimeras presenting defined regions of the human T lymphocyte marker CD4. J. Gen. Virol. 75:969977.
202. Rowe, A.,, G. L. Ferguson,, P. D. Minor,, and A. J. Macadam. 2000. Coding changes in the poliovirus protease 2A compensate for 5'NCR domain V disruptions in a cell-specific manner. Virology 269:284293.
203. Ryan, M. D.,, and M. Flint. 1997. Virus-encoded proteinases of the Picornavirus supergroup. J. Gen. Virol. 78: 699723.
204. Sabin, A. B. 1955. Behavior of chimpanzee-avirulent poliomyelitis viruses in experimentally infected human volunteers. Am. J. Med. Sci. 230:18.
205. Sabin, A. B. 1985. Oral poliovirus vaccine: history of its development and use, and current challenge to eliminate poliomyelitis from the world. J. infect. Dis. 151:420436.
206. Sala, M.,, and S. Wain-Hobson,. 1999. Drift and conservatism in RNA virus evolution: are they adapting or merely changing? p. 115140. In E. Domingo,, R. G. Webster,, and J. J. Holland (ed.), Origin and Evolution of Viruses. Academic Press, San Diego, Calif.
207. Santti, J.,, H. Harvala,, L. Kinnunen,, and T. Hyypia. 2000. Molecular epidemiology and evolution of coxsackievirus A9. J. Gen. Virol. 81:13611372.
208. Santti, J.,, T. Hyypia,, L. Kinnunen,, and M. Salminen. 1999. Evidence of recombination among enteroviruses. J. Virol. 7:87418749.
209. Sarnow, P.,, H. D. Bernstein,, and D. Baltimore. 1986. A poliovirus temperature-sensitive RNA synthesis mutant located in a noncoding region of the genome. Proc. Natl. Acad. Sci. USA 83:571575.
210. Saunders, K.,, A. M. King,, D. McCahon,, J. W. Newman,, W. R. Slade,, and S. Forss. 1985. Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants. J. Virol. 56:921929.
211. Schwerdt, C. E.,, and F. L. Schaffen 1955. Some physical and chemical properties of purified poliomyelitis virus preparations. Ann. N. Y. Acad. Sci. 61:740750.
212. Semler, B. L.,, V. H. Johnson,, and S. Tracy. 1986. A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive. Proc. Natl. Acad. Sci. USA 83: 17771781.
213. Sergiescu, D.,, F. Horodniceanu,, and A. Aubert-Combiescu. 1972. The use of inhibitors in the study of Picornavirus genetics. Prog. Med. Virol. 14:123199.
214. Sevilla, N.,, C. M. Ruiz-Jarabo,, G. Gomez-Mariano,, E. Baranowski,, and E. Domingo. 1998. An RNA virus can adapt to the multiplicity of infection. J. Gen. Virol. 79: 29712980.
215. Sevilla, N.,, N. Verdaguer,, and E. Domingo. 1996. Antigenically profound amino acid substitutions occur during large population passages of foot-and-mouth disease virus. Virology 225:400405.
216. Shepard, D. A.,, B. A. Heinz,, and R. R. Rueckert. 1993. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J. Virol. 67:22452254.
217. Sherry, B.,, and R. Rueckert. 1985. Evidence for at least two dominant neutralization antigens on human rhino-virus 14. J. Virol. 53:137143.
218. Shulman, L. M.,, R. Handsher,, C. F. Yang,, S. J. Yang,, J. Manor,, A. Vonsover,, Z. Grossman,, M. Pallansch,, E. Mendelson,, and O. M. Kew. 2000. Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J. Clin. Microbiol. 38:945952.
219. Sierra, S.,, M. Dävila,, P. R. Lowenstein,, and E. Domingo. 2000. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J. Virol. 74:83168323.
220. Slobodskaya, O. R.,, A. P. Gmyl,, S. V. Maslova,, E. A. Tolskaya,, E. G. Viktorova,, and V. 1. Agol. 1996. Poliovirus neurovirulence correlates with the presence of a cryptic AUG upstream of the initiator codon. Virology 221:141150.
221. Sobrino, F.,, M. Davila,, J. Ortin,, and E. Domingo. 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128:310318.
222. Stanway, G.,, and T. Hyypia. 1999. Parechoviruses. J. Virol. 73:52495254.
223. Stapleton, J. T.,, and S. M. Lemon. 1987. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J. Virol. 61:491498.
224. Stave, J. W.,, J. L. Card,, D. O. Morgan,, and V. N. Vakharia. 1988. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology 62:2129.
225. Stone, D. M.,, J. W. Almond,, J. K. Brangwyn,, and G. J. Belsham. 1993. trans complementation of cap-independent translation directed by poliovirus 5' non-coding region deletion mutants: evidence for RNA-RNA interactions. J. Virol. 67:62156223.
226. Takeda, N.,, M. Tanimura,, and K. Miyamura. 1994. Molecular evolution of the major capsid protein VP1 of enterovirus 70. J. Virol. 68:854862.
227. Teterina, N. L.,, W. D. Zhou,, M. W. Cho,, and E. Ehrenfeld. 1995. Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J. Virol. 69:42454254.
228. Todd, S.,, and B. L. Semler. 1996. Structure-infectivity analysis of the human rhinovirus genomic RNA 3' non-coding region. Nucleic Acids Res. 24:21332142.
229. Todd, S.,, J. S. Towner,, D. M. Brown,, and B. L. Semler. 1997. Replication-competent picornaviruses with complete genomic RNA 3? noncoding region deletions. J. Virol. 71:88688874.
230. Tolskaya, E. A.,, L. I. Romanova,, V. M. Blinov,, E. G. Viktorova,, A. N. Sinyakov,, M. S. Kolesnikova,, and V. I. Agol. 1987. Studies on the recombination between RNA genomes of poliovirus: the primary struture and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants. Virology 161:5462.
231. Tolskaya, E. A.,, L. I. Romanova,, M. S. Kolesnikova,, and V. I. Agol. 1983. Intertypic recombination in poliovirus: genetic and biochemical studies. Virology 124: 121132.
232. Tolskaya, E. A.,, L. I. Romanova,, M. S. Kolesnikova,, A. P. Gmyl,, A. E. Gorbalenya,, and V. I. Agol. 1994. Genetic studies on the NTP-binding pattern containing 2C protein of poliovirus: possible mechanism of guanidine effect on 2C function and evidence for importance of 2C oligomerization. J. Mol. Biol. 236:13101323.
233. Towner, J. S.,, M. M.. Mazanet,, and B. L. Semler. 1998. Rescue of defective poliovirus RNA replication by 3AB-containing precursor polyproteins. J. Virol. 72:71917200.
234. Toyoda, H.,, M. Kohara,, Y. Kataoka,, T. Suganuma,, T. Omata,, N. Imura,, and A. Nomoto. 1984- Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J. Mol. Biol. 174:561585.
235. van Kuppeveld, F. J.,, P. J. van den Hurk,, W. van der Vliet,, J. M. Galama,, and W. J. Melchers. 1997. Chimeric Coxsackie B3 virus genomes that express hybrid coxsackievirus-poliovirus 2B proteins: functional dissection of structural domains involved in RNA replication. J. Gen. Virol. 78:18331840.
236. Wang, J.,, J. M. Bakkers,, J. M. Galama,, H. J. Bruins Slot,, E. V. Pilipenko,, V. I. Agol,, and W. J. Melchers. 1999. Structural requirements of the higher order RNA kissing element in the enteroviral 3'UTR. Nucleic Acids Res. 27:485449.
237. Ward, C. D.,, and J. B. Flanegan. 1992. Determination of the poliovirus RNA polymerase error frequency at eight sites in the viral genome. J. Virol. 66:37843793.
238. Ward, C. D.,, M. A. Stokes,, and J. B. Flanegan. 1988. Direct measurement of the poliovirus RNA polymerase error frequency in vitro. J. Virol. 62:558562.
239. Wecker, E.,, and G. Lederhilger. 1964. Curtailment of the latent period by double infection with polioviruses. Proc. Natl. Acad. Sci. USA 52:246251.
240. Wecker, E.,, and G. Lederhilger. 1964. Genomic masking produced by double infection of HeLa cells with heterotypic polioviruses. Proc. Natl. Acad. Sci. USA 52: 705709.
241. Wien, M. W.,, S. Curry,, D. J. Filman,, and J. M. Hogle. 1997. Structural studies of poliovirus mutants that overcome receptor defects. Nat. Struct. Biol. 4:666674.
242. Wimmer, E.,, C. U. Hellen,, and X. Cao. 1993. Genetics of poliovirus. Annu. Rev. Genet. 27:353436.
243. Xiang, W.,, A. Cuconati,, D. Hope,, K. Kirkegaard,, and E. Wimmer. 1998. Complete protein linkage map of poliovirus P3 proteins: interaction of polymerase 3Dpol with VPg and with genetic variants of 3AB. J. Virol. 72: 67326741.
244. Zell, R.,, K. Klingel,, M. Sauter,, U. Fortmuller,, and R. Kandolf. 1995. Coxsackieviral proteins functionally recognize the polioviral cloverleaf structure of the 5'-NTR of a chimeric enterovirus RNA: influence of species-specific host cell factors on virus growth. Virus Res. 39: 87103.
245. Zhang, G.,, D. T. Haydon,, N. J. Knowles,, and J. W. McCauley. 1999. Molecular evolution of swine vesicular disease virus. J. Gen. Virol. 80:639651.